These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

719 related articles for article (PubMed ID: 26860326)

  • 1. HIV prevalence and risk among people who inject drugs in five South African cities.
    Scheibe A; Makapela D; Brown B; dos Santos M; Hariga F; Virk H; Bekker LG; Lyan O; Fee N; Molnar M; Bocai A; Eligh J; Lehtovuori R
    Int J Drug Policy; 2016 Apr; 30():107-15. PubMed ID: 26860326
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An assessment of an HIV prevention intervention among people who inject drugs in the states of Manipur and Nagaland, India.
    Goswami P; Medhi GK; Armstrong G; Setia MS; Mathew S; Thongamba G; Ramakrishnan L; George B; Singh RK; Paranjape RS; Mahanta J
    Int J Drug Policy; 2014 Sep; 25(5):853-64. PubMed ID: 24925819
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Understanding hepatitis B, hepatitis C and HIV among people who inject drugs in South Africa: findings from a three-city cross-sectional survey.
    Scheibe A; Young K; Moses L; Basson RL; Versfeld A; Spearman CW; Sonderup MW; Prabdial-Sing N; Manamela J; Puren AJ; Rebe K; Hausler H
    Harm Reduct J; 2019 Apr; 16(1):28. PubMed ID: 30975139
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HIV- and hepatitis C-related risk behaviors among people who inject drugs in Uganda: implications for policy and programming.
    Baluku M; Wamala T; Muhangi D
    Harm Reduct J; 2019 Sep; 16(1):56. PubMed ID: 31481086
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparing risk environments for HIV among people who inject drugs from three cities in Northern Mexico.
    Ospina-Escobar A; Magis-Rodríguez C; Juárez F; Werb D; Bautista Arredondo S; Carreón R; Ramos ME; Strathdee S
    Harm Reduct J; 2018 May; 15(1):27. PubMed ID: 29776368
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sexual practices, sexual behavior and HIV risk profile of key populations in Nigeria.
    Ochonye B; Folayan MO; Fatusi AO; Bello BM; Ajidagba B; Emmanuel G; Umoh P; Yusuf A; Jaiyebo T
    BMC Public Health; 2019 Sep; 19(1):1210. PubMed ID: 31477063
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High variability of HIV and HCV seroprevalence and risk behaviours among people who inject drugs: results from a cross-sectional study using respondent-driven sampling in eight German cities (2011-14).
    Wenz B; Nielsen S; Gassowski M; Santos-Hövener C; Cai W; Ross RS; Bock CT; Ratsch BA; Kücherer C; Bannert N; Bremer V; Hamouda O; Marcus U; Zimmermann R;
    BMC Public Health; 2016 Sep; 16(1):927. PubMed ID: 27595567
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Young people who inject drugs in India have high HIV incidence and behavioural risk: a cross-sectional study.
    Ganapathi L; McFall AM; Srikrishnan AK; Kumar MS; Anand S; Lucas GM; Mehta SH; Harris SK; Solomon SS
    J Int AIDS Soc; 2019 May; 22(5):e25287. PubMed ID: 31116005
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of HIV and other infections and injection behaviours among people who inject drugs in Addis Ababa, Ethiopia.
    Demissie M; Johnston LG; Muleta M; Desyebelew D; Belete W; G/Egxiabehre A; Gezahegn N; Kassa D; Aseffa Y
    Afr J AIDS Res; 2018 Sep; 17(3):259-264. PubMed ID: 30319040
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High prevalence of HIV, HBsAg and anti-HCV positivity among people who injected drugs: results of the first bio-behavioral survey using respondent-driven sampling in two urban areas in Mozambique.
    Semá Baltazar C; Horth R; Boothe M; Sathane I; Young P; Chitsondzo Langa D; Condula M; Ricardo H; Dengo Baloi L; Cummings B; Schaad N; Gouveia L; Teodoro E; Raymond HF
    BMC Infect Dis; 2019 Dec; 19(1):1022. PubMed ID: 31791273
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Underreported injection drug use and its potential contribution to reported increase in sexual transmission of HIV in Kazakhstan and Kyrgyzstan.
    Deryabina AP; Patnaik P; El-Sadr WM
    Harm Reduct J; 2019 Jan; 16(1):1. PubMed ID: 30611251
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epidemiology of HIV and hepatitis C infection among women who inject drugs in Northeast India: a respondent-driven sampling study.
    McFall AM; Solomon SS; Lucas GM; Celentano DD; Srikrishnan AK; Kumar MS; Mehta SH
    Addiction; 2017 Aug; 112(8):1480-1487. PubMed ID: 28317210
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Unsafe injecting practices, sexual risk behaviours and determinants of HIV among men who inject drugs: Results from Integrated Biological and Behavioural Surveillance in India.
    Kumar P; Sangal B; Ramanathan S; Ammassari S; Venkatesh SR
    Int J STD AIDS; 2018 Nov; 29(11):1066-1075. PubMed ID: 29747557
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A rapid situation and response assessment of the female regular sex partners of male drug users in South Asia: factors associated with condom use during the last sexual intercourse.
    Kumar MS; Virk HK; Chaudhuri A; Mittal A; Lewis G
    Int J Drug Policy; 2008 Apr; 19(2):148-58. PubMed ID: 18221862
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HIV and hepatitis C prevalence, and related risk behaviours among people who inject drugs in three cities in Croatia: Findings from respondent-driven sampling surveys.
    Handanagic S; Bozicevic I; Civljak M; Dominkovic Z; Sevic S; Barbaric J; Nemeth Blazic T; Dakovic Rode O; Begovac J
    Int J Drug Policy; 2016 Jun; 32():57-63. PubMed ID: 27160504
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rapid situational assessment of people who inject drugs (PWID) in Nairobi and coastal regions of Kenya: a respondent driven sampling survey.
    Oguya FO; Kenya PR; Ongecha F; Mureithi P; Musyoka H; Muraguri N; Mundia B; Angira C; Shose M; Basheeb TA; Mohamed AA; Oyore JP; Ochieng OG; Dida GO; Abdalla S; Abdool R
    BMC Public Health; 2021 Aug; 21(1):1549. PubMed ID: 34391389
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HIV and STI prevalence and injection behaviors among people who inject drugs in Nairobi: results from a 2011 bio-behavioral study using respondent-driven sampling.
    Tun W; Sheehy M; Broz D; Okal J; Muraguri N; Raymond HF; Musyoki H; Kim AA; Muthui M; Geibel S
    AIDS Behav; 2015 Feb; 19 Suppl 1(Suppl 1):S24-35. PubMed ID: 25398417
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HIV infection and risk, prevention, and testing behaviors among injecting drug users -- National HIV Behavioral Surveillance System, 20 U.S. cities, 2009.
    Broz D; Wejnert C; Pham HT; DiNenno E; Heffelfinger JD; Cribbin M; Krishna N; Teshale EH; Paz-Bailey G;
    MMWR Surveill Summ; 2014 Jul; 63(6):1-51. PubMed ID: 24990587
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HIV prevalence, related risk behaviors, and correlates of HIV infection among people who use drugs in Cambodia.
    Sopheab H; Chhea C; Tuot S; Muir JA
    BMC Infect Dis; 2018 Nov; 18(1):562. PubMed ID: 30424727
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Male-to-male sex among men who inject drugs in Delhi, India: overlapping HIV risk behaviours.
    Armstrong G; Jorm AF; Samson L; Joubert L; Singh S; Kermode M
    Int J Drug Policy; 2015 Apr; 26(4):404-11. PubMed ID: 25440911
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.